| Financial Year |
March 31 2023 |
| Monetary Funds |
6,904,193,069.15 |
| Held-for-trading Financial Assets |
306,556,780.90 |
| Notes Receivable |
118,018,968.70 |
| Accounts Receivable |
5,368,397,872.36 |
| Advances to Suppliers |
10,342,933,111.18 |
| Other Receivables |
294,123,918.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
15,061,698,871.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
466,393,359.01 |
| Total Current Assets |
38,994,485,030.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
339,258,899.86 |
| Investment Properties |
45,034,916.23 |
| Fixed Assetes |
507,201,390.52 |
| Under-construction Projects |
416,564,374.57 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
369,432,080.28 |
| R&D expenses |
2,578,611.98 |
| Goodwill |
7,532,791.15 |
| Long-Term Deferred and Prepaid Expenses |
8,722,588.32 |
| Deferred Income Tax Assets |
462,847,565.74 |
| Other Non-Current Assets |
28,583,968.39 |
| Sub-Total of Non-Current Assets |
2,448,999,867.63 |
| Total Assets |
41,443,484,898.13 |
| Short-Term Loans |
7,639,424,279.27 |
| Trading Financial liabilities |
329,573,563.64 |
| Notes Payable |
8,696,640,475.38 |
| Accounts Payable |
4,960,902,925.56 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
344,736,523.30 |
| Taxes Payable |
342,417,946.70 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
316,288,933.10 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
51,339,420.01 |
| Other Current Liabilities |
2,430,862,789.87 |
| Sub-Total of Current Liabilities |
32,538,283,104.58 |
| Long-term Loans |
18,869,955.96 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
108,532,424.46 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
371,425,991.31 |
| Total Liabilities |
32,909,709,095.89 |
| Paid-In Capital(Or Share Stock) |
688,232,979.00 |
| Capital Surplus |
782,750,459.42 |
| Surplus Reserve |
287,529,781.12 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,779,901,046.61 |
| Minority Stockholder's Interest |
2,979,723,800.50 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,554,052,001.74 |
| Owner's Equity（Stockholder's Equity） |
8,533,775,802.24 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
41,443,484,898.13 |
